September 10th 2024
Data showed that vaginal estrogen, vaginal DHEA, oral ospemifene, and vaginal moisturizers may provide benefit in the management of symptoms related to GSM.
Depression, anxiety common in men with pelvic pain
May 1st 2005Istanbul, Turkey--Chronic prostatitis appears to be significantly associated with psychological disorders, such as depression, anxiety, and panic, according to the results of a German study. The study also found that pelvic pain symptoms are far less prevalent than expected (3.2%), while the mean age of afflicted men was significantly higher than noted in previous trials (60.6 years).
TUMT shows durable results in chronic prostatitis
May 1st 2005Istanbul, Turkey--Transurethral microwave thermotherapy of the prostate offers a 50% improvement in pain in up to two-thirds of patients with chronic prostatitis/chronic pelvic pain syndrome, which is comparable to other treatment modalities, according to researcher Christof Kastner, MD, PhD. The therapy also appears to promise good durability 2 years post-procedure.
Biofeedback physical therapy improves CPPS symptoms
May 1st 2005Istanbul, Turkey--Biofeedback physical therapy and pelvic floor re-education appear to offer symptomatic improvement in men with chronic pelvic pain syndrome type III, Dutch researchers say. The techniques appear to work by improving relaxation and demonstrating proper use of pelvic floor muscles.
Look for vulvodynia in patients with IC, pelvic pain
February 1st 2005Oak Brook, IL--Patients with interstitial cystitis may also have vulvodynia, another pelvic pain syndrome that isn't well understood and can be difficult to treat. But research is beginning to tease out the sources of pain, and therapies aimed at treating neuropathic pain seem to offer the most effective approach to treatment today.
Testicular cancer treatment impairs semen quality
January 1st 2005Philadelphia--Treatment for testicular cancer caused the rates of severe oligozoospermia and azoospermia to rise from 7% to 27% and 0% to 12%, respectively, in a study that suggests a need for sperm banking in men treated for the disease.
Transient patency is a problem after vasovasostomy
January 1st 2005Philadelphia--Even after vasovasostomy success, there is a chance that transient patency the "shutting down" of viable sperm production may occur, say researchers from the University of Alabama, Medical College of Wisconsin, and University of Iowa.
Guidelines advise on thrombotic events in urology
January 1st 2005Toronto--Although few published studies exist on the prevention of thromboembolic disorders in urologic surgery, the risk of such disorders appears to be similar to that seen in other major surgical procedures.Therefore, urologists should concentrate on identifying patients at sufficient risk to warrant routine thromboprophylaxis, said the co-author of a new set of antithrombotic guidelines from the American College of Chest Physicians.
Frozen, fresh sperm show similar fertilization rates
January 1st 2005Philadelphia--A new study shows that fertilization rates with cryopreserved sperm are not inferior to those with "fresh" sperm, although it will be several more years before researchers can determine whether the rates are equal in nature.
Sperm concentration, motility decrease as men age
December 1st 2004Caxias do Sul, Brazil--Men over the age of 40 years may have lower semen quality, but not necessarily lower sperm morphology. That's an important fact to remember when evaluating these men for infertility, suggests a study by Brazilian researchers.
Definition of interstitial cystitis still controversial
December 1st 2004Interstitial cystitis is not an uncommon condition, yet researchers continue in their struggle to define it and reach consensus on appropriate diagnostic criteria. In part one of this two-part Urology Times interview, Christopher K. Payne, MD, discusses the current controversy over the definition of IC and his approach to diagnosis.
Definition of interstitial cystitis still controversial
December 1st 2004Interstitial cystitis is not an uncommon condition, yet researchers continue in their struggle to define it and reach consensus on appropriate diagnostic criteria. In part one of this two-part Urology Times interview, Christopher K. Payne, MD, discusses the current controversy over the definition of IC and his approach to diagnosis.
Oral agent shows durable improvement in SUI patients
November 1st 2004San Diego-Treatment with the dual neurotransmitter reuptake inhibitor duloxetine (Yentreve) results in durable improvement in symptoms of stress urinary incontinence, according to a study of open-label transition from placebo to active therapy.
Existing anticholinergics show few CNS effects
November 1st 2004San Diego-Two anticholinergic drugs commonly used in the treatment of overactive bladder have similarly low incidences of adverse events affecting the central nervous system, according to an analysis of data from a large randomized trial of the agents.